Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Abortion Drugs

Abortion Drugs

83 results

Filter Results By

Filter Applied. Clear All
Reset All Filters
83 results
featured-image
Abortion Drugs

The Impact of Chemical Abortion by Mail

Due to the COVID-19 pandemic, the U.S. abortion industry has undergone significant changes. The Food and Drug Administration (FDA) regulates mifepristone, the more dangerous first drug of the two-part chemical abortion cocktail, via a Risk Evaluation and Mitigation Strategy (REMS), which limits how the drug can be dispensed. After years of fighting these safety standards, the abortion industry took advantage of the pandemic to obtain a court order in July 2020 blocking the requirement that mifepristone be administered in person, a key element of the REMS.

Tessa Cox
May 26, 2021
Please login to bookmark Close
Abortion Drugs

FDA Decision to Relax Chemical Abortion Rule Ignores the Science, Neglects Women, Places Them in Danger

"Our review of all the Adverse Events from mifepristone as an abortion drug revealed serious concerns about hemorrhage, infections, and fetal tissue left inside. There were over 500 life-threatening complications, which would have been deaths if the women had not had timely access to the Emergency Room. These women without access to an ER are exactly the women being targeted with abortions by mail, and those who are most at risk of death by patient abandonment. We know from other studies that reports from the FDA only represent a small fraction of the actual adverse events happening to women across the country."

featured-image
Abortion Drugs

Slight Increase in Abortion Rate Largely Due to Surge in Chemical Abortion Nationwide

Today the U.S. Centers for Disease Control (CDC) released new data on abortion rates in 2018. The report generally comports with the preliminary survey of 38 individual state reports released by the Charlotte Lozier Institute (CLI)  in September 2020. CLI’s report similarly found a small increase in the aggregate number of abortions across the country and went deeper to analyze in which states this increase is predominantly occurring and suggest why the increase is happening.

Abortion Drugs

Medical and Social Risks Associated with Unmitigated Distribution of Mifepristone: A Primer

Chemical abortions, or “medication” abortions, have become a more prevalent method of abortion in recent years in the United States. In 2000, the Food and Drug Administration (FDA) approved the use of mifepristone, in conjunction with the drug misoprostol, as an abortion-inducing, two-drug process. By 2018, the Charlotte Lozier Institute estimates that 41% of U.S. abortions were chemically induced.

featured-image
Abortion Drugs

FDA’s Race to Defend Women From Dangerous Drugs

Abortion advocates—seeking to exploit the COVID-19 crisis to advance unfettered access to abortion-inducing drugs—found a friend in federal court.  In mid-July, Judge Theodore D. Chuang issued a preliminary injunction prohibiting the Food and Drug Administration (FDA) from enforcing certain health and safety practices that abortion providers are required to follow when prescribing the only FDA-approved abortion drug regimen.

featured-image
Abortion Drugs

The “No-Test Medication Abortion” Protocol: Experimenting with Women’s Health

A trend of mounting concern is occurring in abortion provision.  When elective induced abortion was legalized in the United States in 1973, one oft-cited motivation was to improve abortion’s safety, as it was frequently claimed that many women were injured and sometimes died from illegal abortions. Recently, abortion advocates have changed their strategy. Whereas once they claimed they wanted abortion to be “safe, legal and rare,” now they favor immediate access and convenience to abortion for all women experiencing unintended pregnancies, regardless of whether it might be more dangerous for a woman, or whether the law prohibits it. Thus, they have begun encouraging women to seek more dangerous, “self-managed” abortions.

featured-image
Abortion Drugs

#AbortionChangesYou: A Case Study to Understand the Communicative Tensions in Women’s Medication Abortion Narratives

Our study is one of the first to analyze women’s narratives after having had a medication abortion. Using relational dialectics theory, we conducted a case study of the nonpartisan website, Abortion Changes You.

featured-image
Abortion Drugs

CLI Responds to Halting of Abortion Pill Trial

“Pro-abortion researchers would rather continue to mislead women about the real risks of the abortion pill regimen Mifeprex than protect them from the risks of this dangerous drug,” said Dr. Tara Sander Lee, CLI’s Senior Fellow and Director of Life Sciences.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image